Innovation Medical(SZ:002173) Sou Hu Cai Jing·2025-09-05 09:40Core Viewpoint - The AI Fund Huashang Innovation Medical Mixed A (017418) reported a profit of 5.2361 million yuan for the first half of 2025, with a weighted average profit per fund share of 0.1359 yuan, and a net value growth rate of 17.87% during the reporting period [2] Group 1: Fund Performance - As of September 3, 2025, the fund's unit net value was 1.121 yuan, with a recent three-month net value growth rate of 25.16%, ranking 65 out of 138 in its category [5] - The fund's six-month net value growth rate was 27.59%, ranking 103 out of 138, while the one-year growth rate was 50.85%, ranking 85 out of 136 [5] - The fund's maximum drawdown since inception was 29.03%, with the largest quarterly drawdown occurring in Q1 2024 at 16.93% [26] Group 2: Fund Holdings and Valuation - As of June 30, 2025, the fund's weighted average price-to-earnings (P/E) ratio was approximately 16.88 times, significantly lower than the category average of 120.96 times [9] - The weighted average price-to-book (P/B) ratio was about 1.09 times, compared to the category average of 4.07 times, and the weighted average price-to-sales (P/S) ratio was approximately 0.99 times, against a category average of 6.52 times [9] - The fund's stock holdings showed a weighted revenue growth rate of 0.04% and a weighted net profit growth rate of 0.19% for the first half of 2025 [14] Group 3: Fund Management and Strategy - The fund manager, Peng Xinyang, oversees three funds, all of which have achieved positive returns over the past year, with the highest being Huashang Industrial Upgrade Mixed Fund at 66.97% [2] - The fund management anticipates that the global collaboration trend in innovative drugs will continue, benefiting the CXO industry from sustained R&D investments [2] - The report highlights the potential for innovative medical devices and the commercialization of medical AI to become new leading themes in the pharmaceutical industry [2] Group 4: Fund Structure and Investor Composition - As of June 30, 2025, the fund had a total of 369 holders, with a total of 37.1517 million shares held [33] - Institutional investors held 53.83% of the shares, while individual investors accounted for 46.17% [33] - The fund's average stock position since inception was 79.64%, with a peak of 90.68% in the first half of 2024 [29]